Drug Type Synthetic peptide |
Synonyms DRx 170, DRx170 |
Target |
Mechanism CRAF inhibitors(C-Raf kinase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Preclinical | GB | 18 Apr 2024 |